US 12,116,416 B2
Targeting intracellular target-binding determinants with intracellular antibodies
Richard H. Weisbart, Sepulveda, CA (US); and Robert N. Nishimura, Sepulveda, CA (US)
Assigned to THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS, Washington, DC (US)
Filed by The United States Government As Represented By The Department Of Veterans Affairs, Washington, DC (US)
Filed on Oct. 6, 2023, as Appl. No. 18/482,643.
Application 15/042,106 is a division of application No. 13/844,318, filed on Mar. 15, 2013, granted, now 9,283,272, issued on Mar. 15, 2016.
Application 18/482,643 is a continuation of application No. 18/322,846, filed on May 24, 2023.
Application 18/322,846 is a continuation of application No. 16/902,173, filed on Jun. 15, 2020.
Application 16/902,173 is a continuation of application No. 15/042,106, filed on Feb. 11, 2016, granted, now 10,683,363, issued on Jun. 16, 2020.
Claims priority of provisional application 61/618,613, filed on Mar. 30, 2012.
Prior Publication US 2024/0026026 A1, Jan. 25, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. C07K 16/30 (2006.01); A61K 39/00 (2006.01); A61P 35/00 (2006.01)
CPC C07K 16/3053 (2013.01) [A61P 35/00 (2018.01); A61K 2039/505 (2013.01); C07K 2317/31 (2013.01); C07K 2317/622 (2013.01)] 5 Claims
 
1. A bispecific antibody comprising the amino acid sequence of SEQ ID NO: 29 or 30.